Parametric Portfolio Associates’s Fennec Pharmaceuticals FENC Stock Holding History

Parametric Portfolio Associates’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,994	Closed	-$104K	–	3660
2021 Q3	$104K	Sell	10,994 -11,441	-51%	-$85.8K	﹤0.01%	3530
2021 Q2	$164K	Sell	22,435 -5,069	-18%	-$33.8K	﹤0.01%	3433
2021 Q1	$171K	Sell	27,504 -53	-0.2%	-$399	﹤0.01%	3907
2020 Q4	$205K	Buy	27,557 +3,395	+14%	+$25.9K	﹤0.01%	3764
2020 Q3	$146K	Buy	24,162 +9,934	+70%	+$70K	﹤0.01%	3730
2020 Q2	$119K	Buy	+14,228	New	+$106K	﹤0.01%	3745
2019 Q2	–	Sell	-42,165	Closed	-$205K	–	3968
2019 Q1	$205K	Buy	42,165 +10,538	+33%	+$69.3K	﹤0.01%	3715
2018 Q4	$202K	Buy	+31,627	New	+$221K	﹤0.01%	3661

Other funds holding FENC

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DG Capital Management New York $231M AUM 39.67% 1-Year Est. Return

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return